The future of cell and gene therapy manufacturing
Pharmaceutical Technology
NOVEMBER 30, 2023
As more cell and gene therapies get approved to treat common conditions, scaling them up will be a challenge.
Thu.Nov 30, 2023
264 
Flagship outlines plans to raise $3B for new fund
Bio Pharma Dive
NOVEMBER 30, 2023
The biotech company creator’s last fund, which closed in 2021, brought in $3.4 billion for investing in new drug startups.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Generation bio cuts 40% of staff in blow for non-viral gene therapy sector
Pharmaceutical Technology
NOVEMBER 30, 2023
The move is a strategic response amid challenges faced by the non-viral gene therapy sector, with several startups closing this year.
CRO disputes Acelyrin’s implication of trial misconduct
Bio Pharma Dive
NOVEMBER 30, 2023
Trial contractor Fortrea is fighting back as Acelyrin unveils a CRO audit in the wake of a major late-stage study failure.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Gliosarcoma drugs in development, 2023
Pharmaceutical Technology
NOVEMBER 30, 2023
GlobalData tracks 49 drugs in development for Gliosarcoma by 39 companies/universities/institutes. The top development phase for Gliosarcoma is phase i, with 22 drugs in that stage.
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
Bio Pharma Dive
NOVEMBER 30, 2023
The acquisition of ImmunoGen gives AbbVie an approved medicine for ovarian cancer, and continues a pharma spending spree on antibody-drug conjugates.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
November 30, 2023: HCSRN Calls for Abstracts and Panel Presentations for 2024 Annual Conference
Rethinking Clinical Trials
NOVEMBER 30, 2023
The Health Care Systems Research Network (HCSRN) is accepting abstract submissions and panel presentation submissions for its 2024 Annual Conference until December 11, 2023. This year’s meeting will be held in Milwaukee, Wisconsin, from April 9 to 11, 2024. The HCSRN is a 20-member research network focused on supporting research institutes aligned with healthcare delivery systems.
Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign
Fierce Pharma
NOVEMBER 30, 2023
With layoffs hitting employees on both sides of the Atlantic, Pfizer’s $3.5 billion cost-cutting spree has kicked it into high gear this month. | The company's Groton, Connecticut, research site is the latest to fall victim to job cuts as part of Pfizer's massive $3.5 billion cost-cutting mission, following layoffs across the U.S. and the U.K.
School of Global Affairs and Ethox Centre launch new research hub
Pharma Times
NOVEMBER 30, 2023
The new hub will unite researchers worldwide to exchange ideas and knowledge - News - PharmaTimes
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
NOVEMBER 30, 2023
The sizzling antibody-drug conjugate (ADC) field is at the center of another major life sciences deal. | The sizzling antibody-drug conjugate field is at the center of another major life sciences deal. Hoping to redeem itself following the epic Rova-T failure, AbbVie is shelling out $10.1 billion in cash to acquire ImmunoGen, maker of the ovarian cancer treatment Elahere.
Herpes Labialis (Oral Herpes) drugs in development, 2023
Pharmaceutical Technology
NOVEMBER 30, 2023
GlobalData tracks 15 drugs in development for Herpes Labialis (Oral Herpes) by 11 companies/universities/institutes. The top development phase for Herpes Labialis (Oral Herpes) is preclinical, with six drugs in that stage.
The Role of Process and Technology Innovation in Advanced Biopharmaceutical Manufacturing
Pharma Mirror
NOVEMBER 30, 2023
By Alexei Voloshin, Global Head of Bioprocess Science, 3M Biopharmaceutical Purification Article Synopsis: Modern biotechnology has brought a revolution in improving the human condition around the world both in terms of quantity and quality. The rapid pace of innovation in biopharmaceutical treatments has enabled the treatment of life-threatening and life-changing conditions such as cancer, inflammation, and infectious disease.
Waning focus on abuse potential may negatively affect pipeline non-stimulants for ADHD
Pharmaceutical Technology
NOVEMBER 30, 2023
Four non-stimulants are currently marketed in at least one of the 7MM: guanfacine, clonidine, atomoxetine and viloxazine.
SMART and CAMP collaborate to develop safer T-cell therapies
Pharma Times
NOVEMBER 30, 2023
The new method successfully performs sterility assessments within 24 hours - News - PharmaTimes
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
CTO Europe 2023: EU’s IVD guidelines continue affecting early clinical work
Pharmaceutical Technology
NOVEMBER 30, 2023
Since its implementation in 2022, new EU regulation for IVDs remains an obstacle for companies in the precision medicine sector.
What to know about colon cancer stages
Antidote
NOVEMBER 30, 2023
Despite the fact that colorectal cancer cases have been declining in the United States since the mid-1980s, it is still the third most common cancer diagnosed each year excluding skin cancer. Often shortened to colon cancer, colorectal cancer occurs when cells in the colon and/or the rectum begin to grow uncontrollably and eventually spread to other parts of the body.
Amgen and MSD-backed start-up wins $10m for drug and device development
Pharmaceutical Technology
NOVEMBER 30, 2023
Culmination Bio has a library of electronic health records and biospecimen data that help in drug and diagnostic device development.
AbbVie agrees $10.1bn deal to buy ImmunoGen
pharmaphorum
NOVEMBER 30, 2023
AbbVie has moved to shore up its pipeline following the loss of patent protection for its top-selling drug with a $10.1 billion deal to buy ImmunoGen and its marketed ovarian cancer drug.
Pharma’s engagement with healthcare providers has slipped in recent years
Pharmaceutical Technology
NOVEMBER 30, 2023
Changing trends show a reduction in HCP contact with the pharma industry and an increased prioritisation of in-person contact.
FDA elevates chief scientist Bumpus to the number two role
pharmaphorum
NOVEMBER 30, 2023
FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year. Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.
Where do anti-tumor necrosis factor like cytokine agents go now?
Pharmaceutical Technology
NOVEMBER 30, 2023
In the past few months, significant interest within the inflammatory bowel disease (IBD) space has been directed towards the therapeutic target, tumour necrosis factor-like cytokine 1A (TL1A).
How to Enable Patient-Centric Co-Design for Better Healthcare Solutions
XTalks
NOVEMBER 30, 2023
Patient-centric co-design refers to an approach where patients or end-users are actively involved with healthcare professionals, designers and other stakeholders to develop healthcare services or products. It allows for the creation of more effective, accessible and user-friendly healthcare solutions that align with the actual needs and desires of patients.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pepper wins $6.5m to develop ‘transomic’ drug discovery platform
Pharmaceutical Technology
NOVEMBER 30, 2023
Pepper’s Compass platform offers insight into the real-time function of proteins which can help in drug discovery.
World AIDS Day 2023: New and Promising Treatments for HIV/AIDS
XTalks
NOVEMBER 30, 2023
Tomorrow is World AIDS Day 2023. Every December 1, the global community comes together to observe World AIDS Day. Originating in 1988, this day serves as a crucial platform for increasing awareness about human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and paying tribute to those whose lives have been impacted by the epidemic.
MSD reinforces Amazon partnership for faster AI-led drug discovery and development
Pharmaceutical Technology
NOVEMBER 30, 2023
MSD is one of many pharma companies migrating IT applications to the cloud to transform value chains and harness new technologies.
UK Biobank releases largest-ever genome sequencing dataset
pharmaphorum
NOVEMBER 30, 2023
UK Biobank releases largest-ever genome sequencing dataset Phil.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
CTO Europe 2023: Fostering diverse oncology trials remains a challenge
Pharmaceutical Technology
NOVEMBER 30, 2023
Experts at the clinical conference continued to explore ways to improve representation in clinical trials and the regulatory push behind it.
PCR in pharma packaging: A sustainable solution for tomorrow?
pharmaphorum
NOVEMBER 30, 2023
PCR in pharma packaging: A sustainable solution for tomorrow? Mike.
Thankful for Opportunities to Stay INTOUCH
Intouch Solutions
NOVEMBER 30, 2023
Some EVERSANA INTOUCH colleagues around the globe observe and celebrate the national holiday of Thanksgiving. In our U.S.-based offices, we gathered for in-office potluck celebrations. During the gatherings, team members exchanged recipes, brought a dish to share with others, and, most importantly, spent time together! “The EVERSANA INTOUCH Friendsgiving potluck was a delight!
How high-intent platforms help pharma brands engage action-oriented customers
Fierce Pharma
NOVEMBER 30, 2023
Way back in 2015 a post on the Think with Google blog made the bold claim that, for marketers, consumer intent is more powerful than demographics: “Intent beats identity. | GoodRx is a trusted, high-intent platform that helps providers and patients find what they need at the exact moment they are looking for something. Learn why intent matters more than demographics.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content